One 2018 study of 11 patients with anti-mGluR5 encephalitis showed that there is an associated tumor about 50% of the time, with neuropsychiatric symptoms predating a diagnosis of neoplasm by two to 11 months [20]. Here, GRM5 is linked to neoplasm.